Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating a vaccine therapy in patients with stage III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED